Owen, Andrew

A living WHO guideline on drugs for covid-19 (2020-2023)

Agarwal, A., Hunt, B. J., Stegemann, M., Rochwerg, B., Lamontagne, F., Siemieniuk, R. A., Agoritsas, T., Askie, L., Lytvyn, L., Leo, Y.-S., et al. (2020) · BMJ

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 1,041

Changes in cardiorespiratory fitness and coronary heart disease risk factors following 24 wk of moderate- or high-intensity exercise of equal energy cost

O'Donovan, G., Owen, A., Bird, S. R., Kearney, E. M., Nevill, A. M., Jones, D. W., & Woolf-May, K. (2005) · Journal of Applied Physiology

Cardiovascular and exercise physiologyPhysical Activity and Health

Cited by 276

Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies

Giardiello, M., Liptrott, N. J., McDonald, T. O., Moss, D., Siccardi, M., Martin, P., Smith, D., Gurjar, R., Rannard, S. P., & Owen, A. (2016) · Nature Communications

Nanoparticle-Based Drug DeliveryDrug Solubulity and Delivery Systems

Cited by 63